Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study
Titel:
Acalabrutinib, venetoclax, and obinutuzumab as frontline treatment for chronic lymphocytic leukaemia: a single-arm, open-label, phase 2 study
Auteur:
Davids, Matthew S Lampson, Benjamin L Tyekucheva, Svitlana Wang, Zixu Lowney, Jessica C Pazienza, Samantha Montegaard, Josie Patterson, Victoria Weinstock, Matthew Crombie, Jennifer L Ng, Samuel Y Kim, Austin I Jacobson, Caron A LaCasce, Ann S Armand, Philippe Arnason, Jon E Fisher, David C Brown, Jennifer R